Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001100412-17-000006
Filing Date
2017-05-10
Accepted
2017-05-10 08:04:07
Documents
62
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a03311710-q.htm 10-Q 1225563
2 EXHIBIT 31.1 a033117ex311.htm EX-31.1 14778
3 EXHIBIT 31.2 a033117ex312.htm EX-31.2 14046
4 EXHIBIT 32.1 a033117ex321.htm EX-32.1 11764
  Complete submission text file 0001100412-17-000006.txt   7119924

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT arry-20170331.xml EX-101.INS 1567110
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arry-20170331.xsd EX-101.SCH 49393
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arry-20170331_cal.xml EX-101.CAL 70121
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arry-20170331_def.xml EX-101.DEF 330916
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arry-20170331_lab.xml EX-101.LAB 702351
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arry-20170331_pre.xml EX-101.PRE 450580
Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address 3200 WALNUT STREET BOULDER CO 80301 3033816600
ARRAY BIOPHARMA INC (Filer) CIK: 0001100412 (see all company filings)

IRS No.: 841460811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-16633 | Film No.: 17828549
SIC: 2834 Pharmaceutical Preparations